CD10 positive thyroid marginal zone non-Hodgkin lymphoma

Journal of Clinical Pathology

Volumn 52, Issue 11, 1999, Pages 849-850

  Millar, E K A ^a   Waldron, S ^a   Spencer, A ^b   Braye, S ^a  

^a JOHN HUNTER HOSPITAL   (Australia)

^b NONE

Author keywords

CD10; Marginal zone non Hodgkin lymphoma

Indexed keywords

ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; DNA;

AGED; ARTICLE; CASE REPORT; EDEMA; EXCISION; FLOW CYTOMETRY; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; THYROID GLAND; TISSUE DISTRIBUTION;

EID: 0032695635     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.52.11.849     Document Type: Article

References (5)

1. Isaacson PG. Malignant lymphomas with a follicular growth pattern. HistoPathology 1996;28:487-95.
2. Isaacson PG, Norton AJ. Malignant lymphoma of the thyroid gland. In: Isaacson PG, Norton AJ, eds. Extranodal lymphomas. Edinburgh: Churchill Livingstone, 1994:103-15.
3. Ballesteros E, Osborne BM, Matsushima AY. CD 5 low-grade marginal zone B-cell lymphomas with localised presentation. Am J Surg Pathol 1998;22:201-7.
4. Jandl JH. Acute lymphatic leukaemia. In: Jandl JH, ed. Blood. Textbook of hematology, 2nd ed. Boston: Little, Brown, 1996:961-89.
5. Phillips AJ, Tomasec P, Wang ECY, et al. Human cytomegalovirus infection downregulates expression of the cellular aminopeptidases CD10 and CD13. Virology 1998;250:350-8.